Advertisement
Loading...

Procaps Group, S.A.

PROCWNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.02
$0.005(33.79%)
U.S. Market opens in 28h 22m

Procaps Group, S.A. Fundamental Analysis

Procaps Group, S.A. (PROCW) shows moderate financial fundamentals with a PE ratio of 2.40, profit margin of 10.38%, and ROE of -2.22%. The company generates $0.4B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position2192.31%
PEG Ratio0.01

Areas of Concern

ROE-2.22%
Current Ratio0.81
We analyze PROCW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 3560.4/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.

Fundamental Health Score

A
3560.4/100

We analyze PROCW's fundamental strength across five key dimensions:

Efficiency Score

Weak

PROCW struggles to generate sufficient returns from assets.

ROA > 10%
9.24%

Valuation Score

Excellent

PROCW trades at attractive valuation levels.

PE < 25
2.40
PEG Ratio < 2
0.01

Growth Score

Weak

PROCW faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

PROCW shows balanced financial health with some risks.

Debt/Equity < 1
-303.86
Current Ratio > 1
0.81

Profitability Score

Weak

PROCW struggles to sustain strong margins.

ROE > 15%
-221.90%
Net Margin ≥ 15%
10.38%
Positive Free Cash Flow
No

Key Financial Metrics

Is PROCW Expensive or Cheap?

P/E Ratio

PROCW trades at 2.40 times earnings. This suggests potential undervaluation.

2.40

PEG Ratio

When adjusting for growth, PROCW's PEG of 0.01 indicates potential undervaluation.

0.01

Price to Book

The market values Procaps Group, S.A. at -108.52 times its book value. This may indicate undervaluation.

-108.52

EV/EBITDA

Enterprise value stands at -1.48 times EBITDA. This is generally considered low.

-1.48

How Well Does PROCW Make Money?

Net Profit Margin

For every $100 in sales, Procaps Group, S.A. keeps $10.38 as profit after all expenses.

10.38%

Operating Margin

Core operations generate 12.76 in profit for every $100 in revenue, before interest and taxes.

12.76%

ROE

Management delivers $-2.22 in profit for every $100 of shareholder equity.

-2.22%

ROA

Procaps Group, S.A. generates $9.24 in profit for every $100 in assets, demonstrating efficient asset deployment.

9.24%

Following the Money - Real Cash Generation

Operating Cash Flow

Procaps Group, S.A. generates limited operating cash flow of $14.10M, signaling weaker underlying cash strength.

$14.10M

Free Cash Flow

Procaps Group, S.A. generates weak or negative free cash flow of $-17.46M, restricting financial flexibility.

$-17.46M

FCF Per Share

Each share generates $-0.17 in free cash annually.

$-0.17

FCF Yield

PROCW converts -17.11% of its market value into free cash.

-17.11%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

2.40

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.005

vs 25 benchmark

P/B Ratio

Price to book value ratio

-108.52

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.25

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-303.86

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.81

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-2.22

vs 25 benchmark

ROA

Return on assets percentage

0.09

vs 25 benchmark

ROCE

Return on capital employed

0.57

vs 25 benchmark

How PROCW Stacks Against Its Sector Peers

MetricPROCW ValueSector AveragePerformance
P/E Ratio2.4028.62 Better (Cheaper)
ROE-221.90%783.00% Weak
Net Margin10.38%-48181.00% (disorted) Strong
Debt/Equity-303.860.39 Strong (Low Leverage)
Current Ratio0.814.12 Weak Liquidity
ROA9.24%-21914.00% (disorted) Weak

PROCW outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Procaps Group, S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ